United States · FDA National Drug Code directory
Praxbind
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0597-0197_9474d542-4726-4546-a768-10d418cdf5cc
- Product NDC
- 0597-0197
- Form
- INJECTION
- Composition / generic term
- idarucizumab
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20151021
- Source listing expiry
- 20261231
Source-listed ingredients
- IDARUCIZUMAB — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 VIAL, SINGLE-DOSE in 1 CARTON (0597-0197-05) / 50 mL in 1 VIAL, SINGLE-DOSE · 0597-0197-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →